Tag: CBT > Cannabis Rescheduling

Cannabis Rescheduling

What to Expect From the DEA’s Cannabis Rescheduling Hearing Transcripts, Final Briefs

A law judge’s recommendation may not come down to whether anti-rescheduling parties proved a Schedule I listing, but whether they disproved the government’s Schedule III evidence.

August 5, 2026

Top Stories

Idaho’s Cannabis Legalization Campaign Effort Leads CBT’s Top Stories in July

Activists submitted signatures to the state secretary at the beginning of the month, after collecting more than double the required number for their petition.

July 29, 2026

Federal Cannabis Legalization

Project Four 2029 Launches to Build Legal Case for Federal Cannabis Rescheduling Ahead of 2029

The new nonpartisan advocacy initiative pairs legal precision with public strategy to prepare the ground for reform before the political window opens.

July 29, 2026

Cannabis Rescheduling

Anti-Rescheduling Groups Attempting to Stay Schedule III Order Call Government’s Response ‘Meritless’

A drug testing group and pharmaceutical company asked a federal court to stay the order, claiming the DOJ has no defense other than diversions.

July 17, 2026

Wyoming

Wyoming Rejects Trump Administration’s Schedule III Cannabis Listing; Keeps It Schedule I

Wyoming Attorney General Keith G. Kautz announced that he won’t loosen restrictions on cannabis after there was little public interest in doing so.

July 8, 2026

Cannabis Rescheduling

Prohibitionists Punch Back at Cannabis Rescheduling Hearing

Anti-rescheduling participants who oppose the Schedule III proposal attempt to expose flaws in a scientific and medical evaluation and discredit DEA witnesses.

July 1, 2026

Cannabis Rescheduling

DEA Comes Out Swinging in Cannabis Rescheduling Hearing

The government argued in support of currently accepted medical use; anti-rescheduling parties attempted to poke holes in the Schedule III recommendation.

June 30, 2026

Cannabis Rescheduling

DEA Plans to Call Pain Management Doctor, FDA Official to Testify at Cannabis Reschedule Hearing

The Drug Enforcement Administration filed a prehearing statement summarizing its two proposed witnesses’ testimony.

June 26, 2026

Massachusetts

MariMed Submits DEA Registration Applications for State-Licensed Medicreschedal Cannabis Businesses

The registration aligns with the federal Schedule III classification, which grants safe harbor to licensed operators and removes Section 280E tax restrictions.

June 25, 2026

Cannabis Rescheduling

DEA Judge Sets Cannabis Hearing Schedule, Won’t Consider More Participants

The administrative law judge declined to consider pleas from non-parties to participate in the rescheduling hearing for the proposed Schedule III rule.

June 25, 2026

Cannabis Rescheduling

Should DEA’s One-Sided Cannabis Rescheduling Hearing Be Reason for Concern?

The government may lack a sufficient administrative record to defend a Schedule III decision in judicial review without any pro-rescheduling participants.

June 24, 2026

Cannabis Rescheduling

Feds Haven’t Provided ‘Clear Guidance, Feedback’ to Ohio on Cannabis Rescheduling

The state’s Division of Cannabis Control ‘doesn’t have a lot of great answers’ for its dual-licensed operators, the department’s legal counsel says.

June 18, 2026